Introduction
============

The neural retina comprises various neurons and glial cells that are generated in a specific temporal order from a common pool of retinal progenitor cells \[[@r1]\]. There is diversity within each type of neuron \[[@r2],[@r3]\], giving rise to complex neuronal networks and information processing \[[@r4]\]. Various molecules, such as transcription factors and neurotrophic factors, have been reported to play important roles in retinal cell differentiation \[[@r5]\].

We are interested in the transition of retinal progenitors during retinal development, and cell surface antigens gave us an opportunity to purify retinal cells at different retinal developmental stages. We found that SSEA-1 labels early embryonic retinal progenitor cells \[[@r6]\], and the c-kit labels retinal progenitor cells at around birth \[[@r7]\]. We then examined the gene expression signature during retinal development, focused on genes specifically expressed in the retinal progenitor at P1, and found that a number of genes specifically expressed in this retinal fraction were related to Müller glia development \[[@r8]\]. *Kcnj10* (Kir4.1) is one of these genes, and we found that downregulation of *Kcnj10* with shRNA in retinal explant resulted in the failure of proper differentiation of the retina, and expression of *Kcnj10* was suppressed by the presence of Notch signaling inhibitor DAPT in the culture \[[@r8]\].

Kcnj10 is an inwardly rectifying potassium channel subunit and well-known since it plays essential roles in the function of the inner ear \[[@r9],[@r10]\] and causes SeSAME/EAST (OMIM [612780](http://omim.org/entry/612780)) syndrome, which is characterized by sensorineural deafness and many neurologic symptoms \[[@r11],[@r12]\]. Many genes have been identified as members of the *Kcnj* family, and the genes were classified into seven subfamilies (*Kir1*--*Kir7*) \[[@r13]\]. They participate in renal epithelial cells \[[@r14]\] and are related to various diseases of the central nervous system \[[@r15]\]. *Kcnj10* was initially isolated in the brain by several groups \[[@r13]\], and is predominantly expressed in brain glial cells \[[@r16]\]. In the retina, *Kcnj10* is expressed in Müller glia of the rat and rabbit eye \[[@r17]\]. However, previous work showed that retinal cells including Müller glia were morphologically normal in the eye of *Kcnj10*-knockout mice \[[@r18]\]. In situ whole-cell patch-clamp recordings showed a tenfold increase in the input resistance and large depolarization of *Kir4.1*-knockout Müller cells \[[@r18]\]. The normal morphological development of the retina of *Kcnj10*-knockout mice was different from our data that sh-RNA-mediated downregulation of *Kcnj10* in retinal progenitor cells resulted in perturbation of morphological differentiation of the retina \[[@r8]\]. In this work, we extended of analysis of the function of *Kcnj10* during retinal development using retinal explant culture in more detail. We found that *Kcnj10* plays pivotal roles in the proliferation of retinal progenitors and maturation of subsets of retinal cells.

Methods
=======

Animals, reagent, and plasmids
------------------------------

All animal experiments were approved by the Animal Care Committee of the Institute of Medical Science, University of Tokyo and conducted in accordance with the guidelines laid down by the U.S. National Institutes of Health regarding the care and use of animals for experimental procedures and the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. ICR mice were obtained from Japan SLC Co (Shizuoka, Japan), and we confirmed that the mice were free of the *Rd1* mutation. The day a vaginal plug was observed was embryonic day 0 (E0), and the day of birth was termed postnatal day 0 (P0). Barium chloride dihydrate (Wako, Osaka, Japan) was dissolved in Hank's Balance Salt Solution (HBSS) at 100 mM. An expression plasmid of sh-Kcnj10 (pU6-shRNA expression vector: mouse U6 promoter in pBluescript-KS \[[@r19]\]) was described in a previous work \[[@r8]\]. Target sequences of sh-Kcnj10 are the first 5′-AAG GAA GTA TTC AGA CTT TAA CA-3′ and second 5′-AAG AGC CAG CTT ATG TGC TTT CA-3′ (Appendix 1). As a control, an empty pU6 vector was used. The efficiency of sh-Kcnj10 was examined using the mouse retina. The isolated retina at E18 was electroporated with 100 μg of sh-Kcnj10 or control vector, and after 48 h, the retinas were harvested. *Kcnj10* levels were examined with RT--PCR using the whole retina. The results were obtained by using the first sh-Kcnj10, and essentially the same main data were obtained with the second sh-Kcnj10. As an enhanced green fluorescent protein (EGFP)-expressing vector, pCAG-EGFP, which is effective for expressing exogenous genes in most retinal subtypes, was used. Quantitative PCR (qPCR) for the *Kcnj* family members was performed using a Roche LightCycler 1.5 apparatus (Roshe, Basel, Switzerland) and was analyzed with the second derivative maximum method for quantification (Roche Diagnostics). The sequence of primers are as follows: *Kcnj10* forward 5′-AGT CTT GGC CCT GCC T-3′, reverse 5′-AGC GAC CGA CGT CAT C-3′, *Kcnj13* forward 5′-TGG ACT TCC ACC TTG A-3′, reverse 5′-TGG AGC AGG GTA GCT A-3′, *Kcnj15* forward 5′-TTG CTG CCA CCT TTG T-3′, 5′-TAA TGC AGG GTG TGT G-3′. β-actin was used as the control. Full-length mouse *Kcnj10* (Appendix 1), which covers from the first ATG to termination codon, was cloned with RT--PCR, and the sequence of an isolated *Kcnj10* clone was confirmed with a DNA sequence. The primers used for cloning were forward 5′-ATG ACG TCG GTC GCT AAG GT -3′ and reverse 5′-TCA GAC GTT GCT GAT GCG CA-3′. Full-length *Kcnj10* was subcloned into downstream of the CAG promoter. Total RNA was purified from the retinas using RNeasy Plus Micro (Qiagen, Venlo, Netherlands), and cDNA was synthesized using SuperScriptII (Life Technologies, Carlsbad, CA).

RNA-sequencing and microarray
-----------------------------

RNA-sequencing (RNA-seq) data were obtained as follows. Total RNA was extracted from the retinas of wild-type C57/BL/6J mice at P7 or P14 using the RNeasy Plus Micro Kit (Qiagen), and the RNA quality was confirmed using a 2100 Bioanalyzer (Agilent Technologies). The DNA microarray was performed using cDNA prepared from the retinal explant from E15 (culture days 0, 5, and 14) using the Affymetrix mouse genome 430 2.0 array (2004).

Retinal explant culture, BrdU incorporation assay, and in vivo electroporation into the retina
----------------------------------------------------------------------------------------------

Retinal explant cultures were prepared as described previously \[[@r20]\]. For the cell proliferation assay, bromodeoxyuridine (BrdU; Sigma-Aldrich, MO; 1.5 μg/ml at final concentration) was added to the explant media, and the retinas were then fixed after 24 h of culture. BrdU was visualized with immunostaining as described previously \[[@r21]\]. For transfection, the U6-Kcnj10 or U6-empty vector was transfected with pCAG-EGFP, which was used as a marker of transfected samples. In vitro plasmid transfection to the isolated mouse retina was performed using electroporation with an Electroporator CUY21 (Nepa Gene, Chiba, Japan) and electrode CYU520P5 (Nepa Gene). Briefly, retinas were transferred to a microelectroporation chamber filled with plasmid solution (25 μg of pCAG-EGFP and 75 μg of sh-Kcnj10 or U6-vector, plasmids were dissolved 1 mg/ml in HBSS), and four square pulses (25 V) of 50 μs duration with 950 μs intervals were applied using the CUY21 pulse generator. In vivo electroporation was performed as previously described \[[@r22]\] with slight modifications. Approximately 0.5 μl of 5 μg/μl DNA solution (mixture of pCAG-EGFP and sh-Kcnj10 or U6-vector, 1:3) was injected into the subretinal space of the P1 mouse retina. Square electric pulses (100 V, six 50-ms pulses at 950-ms intervals) by using a pulse generator, CUY21 SC (Nepa Gene, Japan) were delivered with the CUY650-P5 Platinum Plate Tweezers Electrode (Nepa Gene, Chiba, Japan). The electroporated retinas were harvested at P12.

Immunohistochemistry
--------------------

Immunostaining of frozen sections was done as described previously \[[@r21]\]. Briefly, retinal explants were fixed with 4% paraformaldehyde for 10 min on ice, treated with 25% sucrose for 30 min, embedded in optimum cutting temperature (OCT) compound (Miles), and sectioned (10 μm thickness) using the cryostat (CM3050S, Leica Microsystems, Wetzlar, Germany). The primary antibodies used were mouse monoclonal antibodies anti-glutamine synthetase (Chemicon), PNR (ppmx), HuC/D (Molecular Probes), Ki67 (BD Bioscience), BrdU (Roche Diagnostics), rabbit polyclonal antibodies anti-Calbindin 28k (Chemicon), PNR, Ccnd3 active Caspase-3 (Promega), GFP (BD Biosciences), sheep polyclonal antibody anti-Chx10 (Exalpha Biologicals), and rat polyclonal antibody anti-GFP (Nakarai). Primary antibody signals were visualized using appropriate secondary antibodies conjugated with Alexa 488 or Alexa 594 (Molecular Probes).

Results
=======

Examination of expression of members of the *Kcnj* family in the mouse retina with RNA sequence
-----------------------------------------------------------------------------------------------

Previously, we found that *Kcnj10* was expressed in c-kit-positive retinal progenitor cells, and RT-qPCR analysis indicated that the expression level of *Kcnj10* increased in the later stages of retinal development \[[@r8]\]. We first examined the retinal expression of *Kcnj* family genes with RNA-seq data from whole mouse retinas at P7 and P14. At P7, the expression level of *Kcnj10* was the highest among all *Kcnj* family members considered ([Table 1](#t1){ref-type="table"}). At P14, the highest expression level was observed for *Kcnj14*, although its expression level at P7 was relatively low ([Table 1](#t1){ref-type="table"}). The downregulation of *Kcnj14* in the photoreceptor-specific nuclear receptor (PNR)-knockout retina was reported previously \[[@r23]\], suggesting *Kcnj14* is expressed in photoreceptors. *Kcnj9* also showed a high level of expression at P14. Members of the *Kcnj* family are classified into four sub-families according to their structure; of these, *Kcnj10* belongs to the potassium inwardly-rectifying channel family \[[@r13]\]. *Kcnj1*, -*13*, -*15*, and -*16* belong to the same family, but these members showed negligible retinal expression at P7 and P14 based on our RNA-seq data ([Table 1](#t1){ref-type="table"}). These results suggest that *Kcnj10* is one of the main potassium transport channels of the *Kcnj* family in the retina. Since we used retinal explant culture in the following experiments, we also examined the expression profiles of members of the *Kcnj* family in retinal explants using the gene expression profile of retinal explant cultures. DNA microarray data of retinal explant culture prepared from the mouse retina at E15 (0-day, 5-day, and 14-day cultured retina) was examined ([Table 1](#t1){ref-type="table"}). The *Kcnj10* level increased during explant culture as in vivo, and relatively high expression levels of *Kcnj3*, *-9*, and -*10* were observed in the RNA-seq and microarray data ([Table 1](#t1){ref-type="table"}).

###### Expression of members of Kcnj family in retina and retinal explants.

  Gene name   RNaseq   microarray                                                                                            
  ----------- -------- ------------ ---------------------------------------------------- ------------------ ---------------- -----------------
  Kcnj1       0.01     0.01         1418614_at 1418613_at                                7.2 3.6            10.8 7.6         11.7 3.9
  Kcnj2       1.02     2.83         1422871_at 1450503_at                                4.4 8.6            1.5 7.9          26.7 1.8
  Kcnj3       3.22     6.74         1421468_at                                           48.1               25.5             64.6
  Kcnj4       0.10     0.37         1451808_at                                           5.1                4.8              6.5
  Kcnj5       1.34     6.50         421762_at                                            1.9                8.6              5.8
  Kcnj6       2.23     2.63         11425707_a\_at 1421581_at 1425044_at 1450294_a\_at   1.7 3.9 24.1 1.3   1.5 7.3 16 1.6   4.2 13.5 16.5 1
  Kcnj8       2.31     3.70         1418142_at                                           3.9                1.5              3.1
  Kcnj9       3.70     30.0         1426115_a\_at 1450712_at 1433029_at                  10.7 10.2 9.6      3.7 31.5 2.7     12.3 62.1 10.1
  Kcnj10      6.15     20.34        1419601_at                                           20.3               34.8             50.7
  Kcnj11      3.90     4.25         1450515_at                                           14.3               8.1              6.2
  Kcnj12      2.20     6.65                                                                                                  
  Kcnj13      0.72     2.18         1456418_at                                           10.6               2.7              12.1
  Kcnj14      2.63     240.57                                                                                                
  Kcnj15      0.03     0.03         1450185_at                                           8.1                2.1              1.8
  Kcnj16      0.04     0.17                                                                                                  

RNA sequence was done using RNA extracted from whole retinas of wild type ICR mice. Values of expression levels are FPKM value. wt; wild type. Retinal explant was prepared from E15 retina, and gene expression pattern of culture day 0, 5 and 14 was examined by DNA microarray (Affymetrix). DIV, days in vitro.

Sh-RNA mediated downregulation of *Kcnj10* during retinal development
---------------------------------------------------------------------

We previously showed that the downregulation of *Kcnj10* expression by sh-RNA in retinal explants resulted in malformed retinas \[[@r8]\]. Thus, here we examined the detailed development of retinas in which *Kcnj10* was downregulated with sh-RNA. We transfected an expression plasmid carrying sh-RNA against *Kcnj10* (sh-Kcnj10) into isolated retinas at E18, and the retinas were cultured as explants. We first examined the efficiency of the suppression of the expression level of *Kcnj10* by the expression of sh-Kcnj10 in the retina. The efficiency of electroporation using the mouse retina at around birth is more than 50% (Appendix 1). sh-Kcnj10 was electroporated into the retina at E18, and after 48 h of the culture, the retinas were harvested and subjected to RT-qPCR. The level of *Kcnj10* in sh-Kcnj10 was less than 50% of that in the control (Appendix 1). At the same time, we examined the expression level of *Kcnj13* and -*15*, which are closely related to *Kcnj10* in their structure \[[@r13]\]. The expression level of *Kcnj13* was not changed by the expression of sh-Kcnj10, and that of *Kcnj15* was not detectable in the control and sh-Kcnj10-expressing retina (Appendix 1). We first examined the sub-retinal localization of sh-Kcnj10-expressing cells in the retina ([Figure 1A,B](#f1){ref-type="fig"}). On day 3 of culture, strong EGFP signals were observed the inside the neuroblastic layer; most cells on the outer half of the layer showed weak EGFP signals in the control and sh-Kcnj10 plasmid-transfected groups ([Figure 1A](#f1){ref-type="fig"}). On day 7 of culture, the intensity of the EGFP signal in the cells on the outer side of the neuroblastic layer became stronger than on day 3, and the distribution of EGFP expression between the control and sh-Kcnj10-transfected retinas was similar ([Figure 1A,B](#f1){ref-type="fig"}). On day 14, cells showing strong EGFP positivity were observed in the outer nuclear layer (ONL), but not in the inner nuclear layer (INL) in the control group; in contrast, in the sh-Kcnj10-expressing retina, strong EGFP positivity was observed mostly in the INL ([Figure 1A,B](#f1){ref-type="fig"}). These cells were large compared to the small cells in the ONL, which showed weak EGFP signals ([Figure 1A](#f1){ref-type="fig"}). In addition, a rosette-like structure was observed in the ONL of the sh-Kcnj10-expressing retinas.

![Expression of sh-Kcnj10 in mouse retinal explants. **A**: Control-enhanced green fluorescent protein (EGFP) or sh-Kcnj10/EGFP expression plasmids were electroporated into isolated retinas at E18, and cultured as explants on the indicated days. **B**: Sub-retinal distribution of EGFP-positive cells was calculated on days 7 and 14. **C**, **D**: Proliferated and apoptotic cells were analyzed after 3 days of culture with immunostaining. The population of the immunostaining signal-positive cells (**C**) and immunostained pattern (**D**) are shown. **E**--**H**: Differentiation was examined with immunostaining of markers for retinal subpopulation. Calculation of the population of marker and EGFP double-positive cells in the total EGFP positive cells (**E**, **G**). The number of marker-positive cells in each layer was counted in 150-μm-wide retina (**F**). Staining patterns of GS and EGFP (**H**) are shown. Nuclei were visualized with 4\',6-diamidino-2-phenylindole (DAPI) staining (gray) in **A**, **D**. P value; \* \<0.05, \*\*\<0.01 (the Student *t* test from at least three independent samples). cont, control; sh, sh-Kcnj10; ONL, outer nuclear layer; INL, inner nuclear layer; ONBL, outer neuroblastic layer; GCL, ganglion cell layer; aCasp3, active caspase 3; GS, glutamine synthetase.](mv-v21-148-f1){#f1}

We next examined the proliferative activity in the retinas with BrdU incorporation and Ki67 staining. After 3 days of culture, both analyses showed that the proliferative activity of retinal progenitor cells expressing sh-Kcnj10 was severely suppressed ([Figure 1C,D](#f1){ref-type="fig"}). In addition, the number of apoptotic cells, identified based on the expression of active caspase-3, was slightly increased ([Figure 1C,D](#f1){ref-type="fig"}). We then examined the differentiation of retinal cells with immunostaining for markers of various retinal subtypes. On day 7 in the sh-Kcnj10-expressing retina, few EGFP-positive and Ccnd3-positive Müller glia ([Figure 1E,H](#f1){ref-type="fig"} and Appendix 1) were observed, as expected based on our previous data \[[@r8]\]. The number of Chx10-positive bipolar cells and PNR-positive rods was also significantly decreased ([Figure 1E](#f1){ref-type="fig"} and Appendix 1). On day 14, the number of Müller glia was still low, as shown by counting the number of GS- and Ccnd3-positive cells ([Figure 1F,H](#f1){ref-type="fig"}). In addition, GS staining indicated that the morphology of the Müller glia was severely perturbed ([Figure 1H](#f1){ref-type="fig"}).

The number of PNR-positive rods was still low on day 14 in the sh-Kcnj10-expressing retinas ([Figure 1E](#f1){ref-type="fig"} and Appendix 1), but the number of cells positive for Pax6 and HuC/D, which label amacrine cells, was increased on day 14 in sh-Kcnj10-expressing retina ([Figure 1E](#f1){ref-type="fig"} and Appendix 1). We then counted the total number of HuC/D or Pax6 positive cells in each layer ([Figure 1G](#f1){ref-type="fig"}). We found the cell number of HuC/D or Pax6 in INL was indistinguishable between the control and sh-Kcnj10-expressing samples, but the Pax6 positive cells in the ganglion cell layer (GCL) were slightly increased in the sh-Kcnj10-expressing samples ([Figure 1G](#f1){ref-type="fig"}). Therefore, these results suggest that the increased percentage of amacrine cells in [Figure 1E](#f1){ref-type="fig"} may be caused by the decreased rod photoreceptors rather than the increased number of amacrine cells. We found ectopically localized HuC/D or Pax6-positive cells in the ONL in sh-Kcnj10-expressing samples, but these cells were EGFP negative. We surmise that the cells were miss-localized probably because the Müller glia cells failed to form properly.

Overexpression of *Kcnj10* rescued phenotype induced by sh-Kcnj10
-----------------------------------------------------------------

We then examined the effects of *Kcnj10* overexpression during retinal development. A *Kcnj10* expression plasmid or empty vector was electroporated into isolated retinas at E18 and cultured for the indicated number of days. On day 3, proliferation and apoptosis were examined based on Ki67 or active caspase-3 expression, respectively, and was not perturbed ([Figure 2A](#f2){ref-type="fig"}). We then examined Müller glial cell differentiation. We hypothesized that Müller glial cell differentiation would occur earlier in the *Kcnj10*-overexpressing retina, but a time-course analysis did not support this possibility ([Figure 2B](#f2){ref-type="fig"}).

![Overexpression of *Kcnj10* in retinal explant culture and rescue of phenotype induced by sh-Kcnj10. **A**, **B**: Expression plasmid of *Kcnj10* or empty vector and enhanced green fluorescent protein (EGFP)-expressing plasmid was electroporated into the isolated retina at E18, and cultured for the indicated days. **A**: Proliferation and apoptotic cells were examined with immunostaining of Ki67 or active caspase 3 (aCasp3), respectively. **B**: Immunostaining patterns of 4\',6-diamidino-2-phenylindole (DAPI), EGFP, and glutamine synthetase (GS) are shown. **C**: Control, CAG-Kcnj10, sh-Kcnj10, or CAG-Kcnj10 + sh-Kcnj10 was introduced into the retina at E18, and cultured for 2 weeks. Then, morphology and differentiation were examined with immunostaining of frozen sections. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.](mv-v21-148-f2){#f2}

To confirm that the effect of sh-Kcnj10 was through specific suppression of *Kcnj10* expression, we performed a rescue experiment. A plasmid encoding wild-type *Kcnj10* was transfected with sh-Kcnj10, and the transfected retina was cultured as the explant for 14 days. Differentiation of the retina was examined with immunostaining of frozen sections ([Figure 2C](#f2){ref-type="fig"}). We examined the distribution of the EGFP-positive cells, sub-layer structure, and expression of GS, HuC/D, and PNR, and all criteria indicated the expression of the *Kcnj10* rescued phenotype was induced with sh-Kcnj10.

The phenotype induced by sh-Kcnj10 was mimicked by the presence of Ba^2+^ in retinal explants
---------------------------------------------------------------------------------------------

Since *Kcnj10* encodes a potassium inwardly-rectifying channel \[[@r9]\], we next examined whether the phenotype observed in the absence of *Kcnj10* was related to potassium channel activity using a potassium channel blocker. Almost all known Kir channel subunits are highly sensitive to extracellular Ba^2+^ \[[@r24],[@r25]\], and Ba^2+^ is often used to test the physiologic roles of potassium channels in various tissues, including retinal glial cells \[[@r26]\]. We started retinal explant cultures using retinas at E18 with (0.5 and 10 mM, final concentration) or without Ba^2+^ in the culture medium. After 7 days of culture, we examined the gross morphology and differentiation of the retinal cells with immunostaining ([Figure 3A](#f3){ref-type="fig"}). DAPI staining showed no significant difference between the control and Ba^2+^-treated samples ([Figure 3A](#f3){ref-type="fig"}). The thickness and the cell number of the control and Ba^2+^-treated retinas were indistinguishable ([Figure 3C,D](#f3){ref-type="fig"}). On day 14, the morphology of the 1.0 mM Ba^2+^-treated samples was severely perturbed; a rosette-like structure formed in the ONL, while the INL looked relatively normal ([Figure 3B](#f3){ref-type="fig"}). In addition, the 0.5 mM Ba^2+^-treated samples were much thinner than the control samples on day 14 ([Figure 3D](#f3){ref-type="fig"}). Immunostaining for active caspase-3 revealed a slightly higher number of apoptotic cells in the Ba^2+^-treated (0.5 mM) samples ([Figure 3E,F](#f3){ref-type="fig"}). Immunostaining on days 7 and 14 for retinal markers showed well-developed amacrine cells (Pax6), bipolar cells (Chx10), and photoreceptors (PNR; [Figure 3A,B](#f3){ref-type="fig"}). GS staining of the Ba^2+^-treated retina was relatively normal on day 7 ([Figure 3A](#f3){ref-type="fig"}), but the signal became faint by day 14 ([Figure 3B](#f3){ref-type="fig"}). Since GS was expressed on day 7, we surmise that the commitment of retinal progenitor cells to become Müller glia took place, at least partially, but morphological differentiation did not proceed. We analyzed the effects of Ba^2+^ on Müller glia maturation in greater detail using 0.5 mM Ba^2+^.

![Effects of barium chloride for retinal explants. Retinal explants were prepared from isolated mouse retinas at E18, and cultured as indicated days in the presence or absence of barium chloride (Ba^2+^) in the culture medium. Explants were frozen sectioned, and immunostaining was done with indicated antibodies. **C**: The number of retinal cells, which was counted with 4\',6-diamidino-2-phenylindole (DAPI) signals, in each layer. Numbers of cells of the GCL, and the sum of the INL and the ONL are shown. **D**: The thickness of the INL and the ONL. **E**: Number of active caspase 3 (Casp3) positive cells is shown. Nuclei were visualized with DAPI staining (gray) in **A**, **F**--**H**. P value; \* \<0.05, \*\*\<0.01 (the Student *t* test from at least three independent samples).](mv-v21-148-f3){#f3}

Ba^2+^ exerts effects on retinal development mainly in the late stage of differentiation
----------------------------------------------------------------------------------------

We next set up retinal explant cultures in the presence of Ba^2+^ during either the first or second half of the culture period to examine when the inward potassium current affected Müller glial cell development. Retinal differentiation was examined after 14 days of culture in both cases. When Ba^2+^ was present during the first week of culture, the Müller glia differentiated normally ([Figure 3G](#f3){ref-type="fig"}), suggesting that potassium channel function was dispensable during this period. However, when Ba^2+^ was present during the second week of culture, Müller glia development was severely perturbed. We next divided the culture period into three phases, and Ba^2+^ was added during one of these time periods as follows: 1 to 5, 6 to 10, and 11 to 14 days of culture. The morphology of the Müller glia, which was judged based on the number and location of the cell body and process extension, was quite similar to that of the control when Ba^2+^ was present during the second phase, but it was severely perturbed in the presence of Ba^2+^ during the third phase ([Figure 3H](#f3){ref-type="fig"}). Thus, functional potassium channels may be required during the later stages of retinal differentiation.

Downregulation of Kcnj10 in later stage of retinal development
--------------------------------------------------------------

Our experiments with Ba^2+^ indicated that *Kcnj10* plays a role in postnatal Müller glia differentiation; thus, we examined the effects of sh-Kcnj10 when it was expressed in the postnatal retina. Proliferation stops quickly in the postnatal retina; therefore, we focused on the effects of the downregulation of *Kcnj10* on late-phase retinal differentiation without considering the effects on proliferation. Sh-Kcnj10 was electroporated into isolated retinas at P1, and the retinas were cultured as explants for 12 days. The sub-retinal distribution of EGFP-positive cells showed that, in the controls, most of the EGFP-positive cells were in the ONL ([Figure 4A](#f4){ref-type="fig"}). In contrast, large cells that were strongly positive for EGFP were observed on the inner side of the INL in the sh-Kcnj10-expressing samples, while small cells that were weakly positive for EGFP were observed in the INL and (to a lesser extent) in the ONL ([Figure 4A](#f4){ref-type="fig"}, upper panels). Counting of the cells in each layer showed a clear difference in distribution between the control and sh-Kcnj10-expressing cells ([Figure 4B](#f4){ref-type="fig"}), and the EGFP-positive cells in the ONL of the sh-Kcnj10-expressing samples tended to localize to the inner half of the ONL ([Figure 4B](#f4){ref-type="fig"}). We next examined retinal differentiation by immunostaining for retinal markers. None of the EGFP-positive cells in the sh-Kcnj10-expressing samples expressed Ccnd3 or GS, and few cells in the ONL expressed PNR ([Figure 4D](#f4){ref-type="fig"}, blue arrows). The expression patterns of Chx10, HuC/D, and Pax6 suggest that some of the EGFP-positive cells differentiated into bipolar and amacrine cells; moreover, the staining patterns were similar between the control and sh-Kcnj10-expressing samples (Appendix 1).

![In vitro and in vivo electroporation of sh-Kcnj10 in postnatal retina. **A**-**D**: Control or Kcnj10 expressing plasmids with enhanced green fluorescent protein (EGFP) expression plasmid were electroporated into the isolated retina at P1 (in vitro electroporation) or the retina of live mice at P1 (in vivo electroporation). Then, the retinas were harvested (in vitro samples), or the mice were euthanized, and the retinas were isolated (in vivo samples), and the EGFP and retinal markers were immunostained. **B**: The subretinal distribution of EGFP-positive cells. In the sh-Kcnj10 sample, the outer nuclear layer (ONL) was horizontally divided equally, and the number of cells was counted in each area (the outer half and the inner half of the ONL). **C**: Clonal size was counted by the number of EGFP-positive cells in vertically the same column. **A** and **C** show immunostaining pattern, and nuclei were visualized with4\',6-diamidino-2-phenylindole (DAPI) staining.](mv-v21-148-f4){#f4}

*Downregulation of Kcnj10 by sh-RNA in the* in vivo *retina resulted in failed differentiation of Müller glia*
--------------------------------------------------------------------------------------------------------------

Since the Müller glia of retinas from the *Kcnj10*-knockout mice showed no morphological abnormalities \[[@r18]\], we next asked whether sh-Kcnj10 affects Müller glia development when sh-Kcnj10 is expressed in vivo in the retina. In vivo electroporation was performed using retinas from P1 mouse pups, and the mice were euthanized by cervical dislocation after 12 days. The retinas were then isolated, and their differentiation examined with immunostaining in frozen sections. We first examined the sub-retinal localization of EGFP-positive cells. As seen with in vitro electroporation, after 12 days, the sh-Kcnj10-expressing cells were distributed mainly in the INL ([Figure 4A](#f4){ref-type="fig"}, lower panels). Immunostaining for the Müller glia markers Ccnd3 and GS showed that the sh-Kcnj10-transfected EGFP-positive cells did not differentiate into Müller glia ([Figure 4D](#f4){ref-type="fig"}). Staining for Chx10, HuC/D, and Pax6 showed that some EGFP-positive cells merged with these markers in the control and sh-Kcnj10-expressing retinas, and the staining patterns were similar in these samples (Appendix 1).

Discussion
==========

In this study, we found that *Kcnj10* is required for proper cellular proliferation and differentiation in the retina, especially in the late phase of Müller glia development. Our experiments with Ba^2+^ suggest that the functional effects of Kcnj10 on the retina are mediated through channel activity. Our initial query in this study involved the question of why sh-Kcnj10 affected retinal explants even though Müller glia from *Kcnj10*-knockout mice were reported to be morphologically normal \[[@r18]\]. We first surmised that differences between the retinas in vitro and in vivo (e.g., ionic strength) resulted in the difference in phenotype caused by the downregulation of *Kcnj10*. However, the in vivo downregulation of *Kcnj10* at stage P1 via the expression of sh-Kcnj10 resulted in the failure of appropriate differentiation, suggesting that this explanation was insufficient to elucidate the difference. In terms of structure, *Kcnj13* and *Kcnj15* are closely related to Kcnj10 \[[@r13]\]. Therefore, other members of the *Kcnj* family, which have redundant functions with *Kcnj10*, might be expressed in a compensatory manner in *Kcnj10*-knockout cells. This situation was observed in the case of retinoblastoma protein (Rb). When Rb was genetically knocked out in mice, p107 was upregulated, and functional compensation by p107 or p130 was reported \[[@r27],[@r28]\]. Although we did not observe induction of expression of *Kcnj13* and *Kcnj15* by sh-Kcnj10 in explants, similar examination in the *Kcnj10*-knockout retina may provide conclusive evidence.

We found that the downregulation of *Kcnj10* and treatment with Ba^2+^ resulted in different phenotypes (sh-Kcnj10 suppressed retinal progenitor cell proliferation whereas Ba^2+^ did not). Sh-Kcnj10 expression also perturbed the differentiation of bipolar cells and rods, which are late-differentiating cell types; therefore, we surmise that the phenotype was secondary to the effects of suppression on proliferation rather than fate change of retinal progenitors. *Kcnj16* modulates Kcnj10 channel conductance \[[@r29]\], and heteromeric Kcnj10/16 channels were reported to be expressed in Müller glia \[[@r13]\]. Perturbation of the stoichiometry of Kcnj10 with interacting molecules by sh-Kcnj10 may be one cause of the phenotypic differences that resulted from sh-Kcnj10 and Ba^2+^ treatment. Interestingly, perisynaptic processes and the end feet of Müller cells harbor homomeric or heteromeric Kcnj channels in opposite directions to the cell membrane \[[@r13]\]. Therefore, a lack of *Kcnj10* in Müller glia may result in complex phenotypes compared with simple blockage of the channel from the outside. However, *Kcnj10* overexpression had no effect on retinal development. The modification of *Kcnj10* by pH is well-known. PtdIns(4,5)P2 also modifies *Kcnj10* function, and binding proteins such as Mag1 regulate the localization of *Kcnj10* \[[@r30]\]. We suspect that these modifiers did not function appropriately for exogenous *Kcnj10*, or that retinal *Kcnj10* expression may have been saturated when we overexpressed *Kcnj10*.

A previous study indicated the negative involvement of Kcnj10 in proliferation during wound healing in human corneal epithelial cells through calcium signaling \[[@r31]\]. Ba^2+^ treatment also promoted the proliferation of neural precursor cells \[[@r32]\]. Therefore, our observations may not be explained by simple blockage of the inward potassium current. In the case of Kv potassium channels, the involvement of Kv channels in epithelial cell proliferation has been reported, and Kv4.1 is related to gastric cancer cell proliferation \[[@r33]\]. Kv and Kir channels are clearly different channels, but calcium mobilization occurs downstream of both channels. The positive involvement of calcium signaling in cellular proliferation under certain situations by Kv4.1 and Kcnj10 is one possible mechanism.

Changes in the Kcnj10 level in Müller glial cells of RGS rats during retinal degeneration has been reported \[[@r34]\]. In addition to changing the membrane potential of Müller glia during degeneration, changes in membrane potential have also been demonstrated during Müller glia development \[[@r35],[@r36]\]. At an early stage of Müller glia differentiation, no inward potassium current was observed; however, the inward current increased during maturation of the cells. These results suggest important roles for potassium channels in Müller glia development. Taken together, in this study we uncovered a role for *Kcnj10* in retinal development using an explant culture system and an in vivo electroporation system. Further molecular analysis using these systems may shed new light on the role and molecular mechanisms of *Kcnj10* in retinal development.
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